Abrogating HSP response augments cell death induced by As2O3 in glioma cell lines

Canadian Journal of Neurological Sciences

Volumn 37, Issue 4, 2010, Pages 504-511

  Song, Xueming ^a   Chen, Zhiqiang ^a   Wu, Chunbo ^a   Zhao, Shiguang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; BIOLOGICAL MARKER; CASPASE 3; DNA; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HEAT SHOCK TRANSCRIPTION FACTOR 1; KNK 437; PROTEIN INHIBITOR; SMALL INTERFERING RNA; TRYPAN BLUE; UNCLASSIFIED DRUG; 2 PYRROLIDONE DERIVATIVE; ANTINEOPLASTIC AGENT; BENZHYDRYL DERIVATIVE; DNA BINDING PROTEIN; ENZYME INHIBITOR; HEAT SHOCK TRANSCRIPTION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; ORGANOARSENIC DERIVATIVE; OXIDE; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DNA CONTENT; DRUG MECHANISM; DRUG POTENTIATION; FLOW CYTOMETRY; GLIOMA CELL; HEAT SHOCK; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; WESTERN BLOTTING; CELL DEATH; DIAGNOSTIC USE; DOSE RESPONSE; DRUG EFFECTS; DRUG INTERACTION; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; HEAT SHOCK RESPONSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TIME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; ARSENICALS; BENZHYDRYL COMPOUNDS; CASPASE 3; CELL DEATH; CELL LINE, TUMOR; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HEAT-SHOCK PROTEINS; HEAT-SHOCK RESPONSE; HUMANS; MAP KINASE KINASE 4; MEMBRANE POTENTIAL, MITOCHONDRIAL; OXIDES; PYRROLIDINONES; RNA, SMALL INTERFERING; TIME FACTORS; TRANSCRIPTION FACTORS; TRYPAN BLUE;

EID: 77953350363     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100010544     Document Type: Article

References (33)

1. Berger F, Gay E, Pelletier L, Tropel P, Wion D. Development of gliomas: potential role of asymmetrical cell division of neural stem cells. Lancet Oncol. 2004;5(8):511-514
2. Carpentier AF. Neuro-oncology: the growing role of chemotherapy in glioma. Lancet Neurol. 2005;4(1):4-5.
3. Jeong M, Kwon YS, Park SH, Kim CY, Jeun SS, Song KW, et al. Possible novel therapy for malignant gliomas with secretable trimeric TRAIL. PLoS One. 2009;4(2):e4545.
4. Zhao S, Zhang X, Zhang J, Zhang J, Zou H, LiuY, et al. Intravenous administration of arsenic trioxide encapsulated in liposomes inhibits the growth of C6 gliomas in rat brains. J Chemother. 2008;20(2):253-262
5. Zhao S, Zhang J, Zhang X, Dong X, Sun X. Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status. Mol Biol Rep. 2008;35(3):421-429
6. Zhao S, Tsuchida T, Kawakami K, Shi C, Kawamoto K. Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioblastoma cell lines differing in p53 status. Int J Oncol. 2002;21(1):49-55.
7. Simeonova PP, Wang S, Toriuma W, Kommineni V, Matheson J, Unimye N, et al. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res. 2000;60(13):3445-3453
8. Miller WH Jr, Schipper HM, Lee JS, Singer J, Waxman S. Mechanisms of action of arsenic trioxide. Cancer Res. 2002;62 (14):3893-3903
9. Wu YC, Yen WY, Lee TC, Yih LH. Heat shock protein inhibitors, 17-DMAG and KNK437, enhance arsenic trioxide-induced mitotic apoptosis. Toxicol Appl Pharmacol. 2009;236(2):231-238
10. Yih LH, Peck K, Lee TC. Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment. Carcinogenesis. 2002;23(5):867-876
11. Dilda PJ, Hogg PJ. Arsenical-based cancer drugs. Cancer Treat Rev. 2007;33(6):542-564
12. Liu B, Pan S, Dong X, Qiao H, Jiang H, Krissansen GW, et al. Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice. Cancer Sci. 2006;97(7):675-681
13. Liu J, Kadiiska MB, Liu Y, Lu T, QuW,Waalkes MP. Stress-related gene expression in mice treated with inorganic arsenicals. Toxicol Sci. 2001;61(2):314-320
14. Khalil S, Luciano J, Chen W, Liu AY. Dynamic regulation and involvement of the heat shock transcriptional response in arsenic carcinogenesis. J Cell Physiol. 2006;207(2):562-569
15. Wetzler M, Earp JC, Brady MT, Keng MK, Jusko WJ. Synergism between arsenic trioxide and heat shock protein 90 inhibitors on signal transducer and activator of transcription protein 3 activity- -pharmacodynamic drug-drug interaction modeling. Clin Cancer Res. 2007;13(7):2261-2270
16. Arndt V, Rogon C, Höhfeld J. To be, or not to be - molecular chaperones in protein degradation. Cell Mol Life Sci. 2007;64 (19-20):2525-2541
17. Picard D. Heat-shock protein 90, a chaperone for folding and regulation. Cell Mol Life Sci. 2002;59(10):1640-1648
18. Brodsky JL, Chiosis G. Hsp70 molecular chaperones: emerging roles in human disease and identification of small molecule modulators. Curr. Top Med Chem. 2006;6(11):1215-1225
19. Camphausen K, Tofilon PJ. Inhibition of Hsp90: a multitarget approach to radiosensitization. Clin Cancer Res. 2007;13(15 Pt 1):4326-4330
20. Jiang B, Xiao W, Shi Y, Liu M, Xiao X. Heat shock pretreatment inhibited the release of Smac/DIABLO from mitochondria and apoptosis induced by hydrogen peroxide in cardiomyocytes and C2C12 myogenic cells. Cell Stress Chaperon. 2005;10(3): 252-262
21. Beere HM,Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, et al. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol. 2000;2(8):469-475
22. Bivik C, Rosdahl I, Ollinger K. Hsp70 protects against UVB induced apoptosis by preventing release of cathepsins and cytochrome c in human melanocytes. Carcinogenesis. 2007;28 (3):537-544
23. Beere HM. Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest. 2005;115(10):2633-2639
24. Bross PF, Kane R, Farrell AT, Abraham S, Benson K, Brower ME, et al. Approval summary for bortezomib for injection in the treatment of multiple myeloma. Clin Cancer Res. 2004;10(12 Pt 1):3954-3964
25. Westerheide SD, Morimoto RI. Heat shock response modulators as therapeutic tools for diseases of protein conformation. J Biol Chem. 2005;280(39):33097-33100
26. Jolly C, Morimoto RI. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst. 2000;92(19):1564-1572
27. Gorman AM, Heavey B, Creagh E, Cotter TG, Samali A. Antioxidant-mediated inhibition of the heat shock response leads to apoptosis. FEBS Lett. 1999;445(1):98-102.
28. Khalil S, Luciano J, Chen W, Liu AY. Dynamic regulation and involvement of the heat shock transcriptional response in arsenic carcinogenesis. J Cell Physiol. 2006;207(2):562-569
29. Gabai VL, Meriin AB, Mosser DD, Caron AW, Rits S, Shifrin VI, et al. Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance. J Biol Chem. 1997;272 (29):18033-18037
30. Gabai VL, Yaglom JA, Volloch V, Meriin AB, Force T, Koutroumanis M, et al. Hsp72-mediated suppression of c-Jun Nterminal kinase is implicated in development of tolerance to caspase-independent cell death. Mol Cell Biol. 2000;20(18): 6826-6836
31. Park HS, Lee JS, Huh SH, Seo JS, Choi EJ. Hsp72 functions as a natural inhibitory protein of c-Jun N-terminal kinase. EMBO J. 2001;20(3):446-456
32. Volloch V, Gabai VL, Rits S, Force T, Sherman MY. HSP72 can protect cells from heat-induced apoptosis by accelerating the inactivation of stress kinase JNK. Cell Stress Chaperones. 2000;5(2):139-147
33. Gabai VL, Meriin AB, Yaglom JA, Wei JY, Mosser DD, Sherman MY. Suppression of stress kinase JNK is involved in HSP72- mediated protection of myogenic cells from transient energy deprivation. HSP72 alleviates the stress-induced inhibition of JNK dephosphorylation. J Biol Chem. 2000;275(48):38088-38094